Table: Kobayashi Pharmaceutical -2023 group results

Kobayashi Pharmaceutical

09/02/2024 06:00

Feb 9 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2023    Dec 31, 2022   Dec 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            173.46          166.26         185.60                 
                 (+4.3 pct)      (+7.1 pct)     (+7.0 pct)               
  Operating         25.78           26.67          26.30                 
                 (-3.3 pct)      (+2.3 pct)     (+2.0 pct)               
  Recurring         27.33           28.28          27.50                 
                 (-3.4 pct)      (+1.0 pct)     (+0.6 pct)               
  Net
  Net               20.34           20.02          20.50                 
                 (+1.6 pct)      (+1.6 pct)     (+0.8 pct)               
  EPS            268.16 yen      259.63 yen     275.76 yen               
  EPS Diluted                    259.59 yen                              
  Ann Div        101.00 yen       90.00 yen     103.00 yen               
  -Q2 Div         43.00 yen       38.00 yen      44.00 yen               
  -Q4 Div         58.00 yen       52.00 yen      59.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T